Responses
Congenital heart disease
Effect of the oral endothelin antagonist bosentan on the clinical, exercise, and haemodynamic status of patients with pulmonary arterial hypertension related to congenital heart disease
Compose a Response to This Article
Other responses
No responses have been published for this article.